title: Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV co-infected patients.
authors.forename: T
authors.initials: T
authors.lastname: Bader
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005229:Fatty Acids, Monounsaturated / Q000009:adverse effects* / Q000627:therapeutic use; D000077340:Fluvastatin; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D016174:Hepacivirus / Q000187:drug effects / Q000254:growth & development*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood; D016032:Randomized Controlled Trials as Topic; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D012367:RNA, Viral; D000077340:Fluvastatin